GI Oncology
From the Journals
USPSTF reaffirms recommendation against pancreatic cancer screening in asymptomatic adults
After a systematic review of 13 studies related to the harms and benefits of screening for pancreatic cancer, the task force reaffirmed its 2004...
From the Journals
Lynch syndrome screening shows low efficiency in elderly
Of 63 Lynch syndrome cases detected by universal screening, 5 (7.9%) were identified over age 70 years and 1 (1.6%) was detected over age 80 years...
From the Journals
Clopidogrel matches aspirin for reducing risk of colorectal cancer
The study authors hypothesize that the chemoprotective effect of low-dose aspirin is mediated mostly through the permanent inactivation of...
From the Journals
Colorectal cancer diagnoses still moving up in younger adults, with no sign of plateau
Incidence increased from 10% to 12% over a decade in the analysis of a large U.S. cancer registry.
From the Journals
Test could inform care of patients with pancreatic cysts
The test, CompCyst, correctly identified 91% of patients who required surgery, 49% of those who required monitoring, and 60% of patients who...
From the Journals
Genomic study reveals five subtypes of colorectal cancer
Drug treatments may be developed for cancers that genetic analyses have identified as having different methylation subtypes.
Video
Study finds differences for HCC in women
SAN DIEGO – Women were significantly more likely to present without cirrhosis and with nonalcoholic fatty liver disease than were men.
Conference Coverage
SEER data show that pancreatic cancer mortality rates differ by ethnicity
SAN DIEGO – Between 2013 and 2015, mortality rates began to fall among all ethnicities, for reasons that remain unclear.
Clinical Review
Advanced Melanoma: Treatment After Progression on First-line Therapy
From the Journals
Pancreatic cancers often contained targetable mutations
A total of 17% of specimens harbored mutations that are potentially targetable with existing therapies. These mutations involved either RTK/ras/...
From the Journals
ctDNA predicts recurrence in nonmetastatic colorectal cancer
The sensitivity of ctDNA testing for disease recurrence was 100%, compared with 60% for CEA testing, in an observational study of 58 patients with...